Clinical trial
A Multiple-center, Self-controlled Open Study to Evaluate Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
NCT01190657 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multiple-center, Self-controlled Open Study to Evaluate Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- February 28, 2013
- Enrollment
- 1,184 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
acute gastritis, gastric ulcer